Pediatric aspergillosis - Disease and treatment differences in children

被引：63

作者：

Steinbach, WJ ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Durham, NC 27710 USA

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2005年 / 24卷 / 04期

关键词：

pediatric; aspergillosis; Aspergillus; voriconazole; caspofungin; galactomannan;

D O I：

10.1097/01.inf.0000157218.37603.84

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Invasive aspergillosis is an increasing problem, yet there are few specific data on pediatric aspergillosis. The underlying patient diseases and treatments differ in children and adults, and there is a heterogeneity of invasive aspergillosis that extends to children. Although new diagnostic tools hold great promise for adult patients, it appears that they have limited usefulness in children without the appropriate testing. Antifungal management of pediatric aspergillosis also requires unique dosing schemes that are not used in adult patients.

引用

页码：358 / 364

页数：7

共 65 条

[1] Aspergillosis in children with cancer: A 34-year experience [J].

Abbasi, S ;

Shenep, JL ;

Hughes, WT ;

Flynn, PM .

CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) :1210-1219

[2] PULMONARY FUNGAL-INFECTIONS AFTER BONE-MARROW TRANSPLANTATION [J].

ALLAN, BT ;

PATTON, D ;

RAMSEY, NKC ;

DAY, DL .

PEDIATRIC RADIOLOGY, 1988, 18 (02) :118-122

[3] Infections diagnosed in the first year after pediatric stem cell transplantation [J].

Benjamin, DK ;

Miller, WC ;

Bayliff, S ;

Martel, L ;

Alexander, KA ;

Martin, PL .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (03) :227-234

[4] Invasive aspergillosis in allogeneic stem cell transplant recipients: Increasing antigenemia is associated with progressive disease [J].

Boutboul, F ;

Alberti, C ;

Leblanc, T ;

Sulahian, A ;

Gluckman, E ;

Derouin, F ;

Ribaud, P .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (07) :939-943

[5] A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients [J].

Bowden, R ;

Chandrasekar, P ;

White, MH ;

Li, X ;

Pietrelli, L ;

Gurwith, M ;

van Burik, JA ;

Laverdiere, M ;

Safrin, S ;

Wingard, JR .

CLINICAL INFECTIOUS DISEASES, 2002, 35 (04) :359-366

[6] Serum Aspergillus galactomannan antigen testing by sandwich ELISA: Practical use in neutropenic patients [J].

Bretagne, S ;

MarmoratKhuong, A ;

Kuentz, M ;

Latge, JP ;

BartDelabesse, E ;

Cordonnier, C .

JOURNAL OF INFECTION, 1997, 35 (01) :7-15

[7] Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience [J].

Cesaro, S ;

Strugo, L ;

Alaggio, R ;

Cecchetto, G ;

Rigobello, L ;

Pillon, M ;

Cusinato, R ;

Zanesco, L .

SUPPORTIVE CARE IN CANCER, 2003, 11 (11) :722-727

[8]

CHACHATY E, 2003, 15 C INT SOC HUM AN

[9] FUNGAL INFECTION IN CHRONIC GRANULOMATOUS-DISEASE - THE IMPORTANCE OF THE PHAGOCYTE IN DEFENSE AGAINST FUNGI [J].

COHEN, MS ;

ISTURIZ, RE ;

MALECH, HL ;

ROOT, RK ;

WILFERT, CM ;

GUTMAN, L ;

BUCKLEY, RH .

AMERICAN JOURNAL OF MEDICINE, 1981, 71 (01) :59-66

[10] Epidemiology of invasive aspergillosis in France:: a six-year multicentric survey in the Greater Paris area [J].

Cornet, M ;

Fleury, L ;

Maslo, C ;

Bernard, JF ;

Brücker, G .

JOURNAL OF HOSPITAL INFECTION, 2002, 51 (04) :288-296

← 1 2 3 4 5 6 7 →